In
the coronary arteries Drug-Eluting Balloons (DEBs) have emerged as an exciting
technology developed to overcome the limitations faced by drug-eluting stents,
such as stent thrombosis and dependency on prolonged dual antiplatelet therapy,
and may prove efficacious in complex subsets such as small vessels and diffuse
lesions.
In particular, DEBs are commonly used in the coronary arteries to
prevent restenosis, to treat in-stent restenosis, to treat small vessels, and
to treat vessels where stent results are suboptimal.In the last year’s drug
eluting technology (balloons and stents) moved from coronary to peripheral
arteries. Manufacturers supported the evolution of these devices. Eight
randomized controlled trials have been already published about the use of DEBs
in femoro-popliteal and below-the-knee arteries. About ten clinical trials are
still ongoing (supported by three different manufacturers). Read more>>>>>>>>>>>>
No comments:
Post a Comment